Jeffrey Davis

Subscribe to Jeffrey Davis's Posts

Jeffrey is a skilled healthcare executive with substantial knowledge of regulatory advocacy and healthcare policies. Jeffrey’s work focuses on issues tied to provider payment and reimbursement as well as quality reporting. He also has significant experience with recent regulatory developments such as the implementation of surprise billing rules. Read Jeffrey Davis's full bio.

HHS, Labor, and Treasury Finalize Mental Health Parity Rule

By Katie Waldo, Rachel Stauffer, Erica Stocker, Jeffrey Davis, Leigh Feldman, Julia Grabo and Maddie News on Sep 26, 2024
Posted In Employee Benefits, Health and Welfare Plans, Mental Health Parity and Addiction Equity Act

On September 9, 2024, the US Departments of Health and Human Services , Labor, and the Treasury finalized a rule related to the Mental Health Parity and Addiction Equity Act. This rule introduces significant updates to mental health and substance use disorder benefits, ensuring parity with medical and surgical benefits. Key changes include enhanced protections...

Continue Reading

Regs, Regs and More Regs: The Biden Administration Releases Spring 2024 Unified Agenda

By Jeffrey Davis on Aug 8, 2024
Posted In Employee Benefits, Health and Welfare Plans, Mental Health Parity and Addiction Equity Act

The Biden administration recently released its Spring 2024 Unified Agenda (a few months late), which lists all the regulations that the administration plans to issue by the end of the year and beyond. In this update, Jeffrey Davis previews new regulations that could impact the health and welfare benefits industry related to the No Surprises...

Continue Reading

Telehealth: Regulatory Questions Amid Legislative Uncertainty

By Jeffrey Davis and Rachel Stauffer on Jul 18, 2024
Posted In Digital Health, Health and Welfare Plans

One year on from the end of the COVID-19 public health emergency, the Medicare restrictions on telehealth that Congress waived to allow for and expand the use of telehealth and other forms of virtual care are set to expire. Congress has already acted twice to extend the waivers, most recently in the Consolidated Appropriations Act,...

Continue Reading

Surprise Medical Billing Law ‘Not Working the Way We Want It to Work’

By Jeffrey Davis on May 20, 2024
Posted In Executive Compensation, Health and Welfare Plans

A legislative fix to surprise medical billing is not working the way lawmakers imagined it would work. According to this Politico Pro article, private equity groups are disproportionately benefiting from the No Surprises Act, and the law may inadvertently lead to higher health insurance premiums. Access the article.

Continue Reading

Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel Medications

By Jeffrey Davis, Paul Radensky, Parashar Patel and Amy Kelbick on May 15, 2024
Posted In Employee Benefits, Health and Welfare Plans

The Centers for Medicare & Medicaid Services (CMS) announced in March that it would allow health plans under Medicare Part D (the Medicare prescription drug benefit) to cover Wegovy and other weight-loss medications if they receive Food and Drug Administration (FDA) approval for an additional medically accepted indication. In Wegovy’s case, the FDA recently approved an additional...

Continue Reading

2024 Chart of Healthcare Regulations

By Kristen O'Brien, Rachel Stauffer, Katie Waldo and Jeffrey Davis on Apr 24, 2024
Posted In Employee Benefits, Health and Welfare Plans

During this election year, McDermottPlus is actively monitoring annual regulations that federal agencies are expected to release, as well as “ad hoc” regulations that will be released at the discretion of federal agencies. This chart displays health-related regulations that may be issued this year, organized by federal agency and date of potential release. Access the...

Continue Reading

Doctors Question Medicare Quality Program as More Face Steeper Penalties

By Jeffrey Davis on Nov 28, 2023
Posted In Employee Benefits, Health and Welfare Plans

A Medicare program designed to incentivize high-quality care via physician bonuses is in doubt as providers say it’s caused more trouble than it’s worth. According to this Axios article, the Merit-Based Incentive Payment System has created a disparity between bonus winners and losers, and this disparity is only expected to grow. Access the article.

Continue Reading

Surprise Billing Arbitration Is Still a Mess

By Jeffrey Davis on Nov 22, 2023
Posted In Employee Benefits, Health and Welfare Plans

Despite a two-year-old ban on surprise medical billing, insurers and providers are struggling to resolve unpaid claims. In this Axios article, McDermott+Consulting’s Jeffrey Davis offers perspective on the state of the claims resolution process. Read more here.

Continue Reading

Patients May Not Feel Benefits of Medicare Drug Price Negotiations

By Jeffrey Davis on Oct 4, 2023
Posted In Employee Benefits, Health and Welfare Plans, Uncategorized

The Biden administration recently announced a list of Medicare-covered drugs that will be subject to price negotiations. The administration said the negotiations—a reality thanks to the Inflation Reduction Act—will benefit nearly nine million seniors. However, according to this Insider article, some drug-policy analysts seem unconvinced by the administration’s claims. Access the article.

Continue Reading